Attorney John Gardella was recently interviewed by Pat Rizzuto, reporter for Bloomberg Law, for her article regarding changes that appear to be coming to the Restatement (Third) of Torts with respect to explicit support for medical monitoring lawsuits, even in the absence of underlying realized injuries by the plaintiffs. Ms. Rizzuto is a Senior Chemicals’ Reporter for Bloomberg Law that has closely following and published on PFAS issues for several years. Ms. Rizzuto’s article examines in detail two important factors important to PFAS medical monitoring issues – the judicial system’s treatment of medical monitoring claims to date and the lack of knowledge within the medical community regarding PFAS and testing options for patients. Attorney Gardella was interviewed for his insights into how a possible change to the Restatement will impact PFAS litigation.
For the complete article and Ms. Rizzuto’s PFAS thought content, please visit Bloomberg News here:
CMBG3 Law is following judicial, legislative, administrative, and scientific developments relating to PFAS. More information about the services we can provide, including risk assessments, to ensure your business is ready for any intersection with these substances can be found on our PFAS Litigation page.
Our attorneys have been at the forefront of PFAS issues, including giving presentations as to the future waves of litigation stemming from PFAS issues. For more information, please contact the Chair of our PFAS – Toxic Torts Team: John Gardella.